Markets:

Overview

News

Currencies

International

Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

5.675 -0.355 (-5.89%)

Streaming Delayed Price Updated: 11:39 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 28, 2023

From Savara Inc.

Via Business Wire

JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 21, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Savara Announces New Leadership Appointments

February 14, 2023

From Savara Inc.

Via Business Wire

Why Shares of Savara Soared This Week ↗

January 27, 2023

The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.

Via The Motley Fool

Savara Announces New Employment Inducement Grant

January 20, 2023

From Savara Inc.

Via Business Wire

$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

January 04, 2023

The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Savara Announces New Employment Inducement Grant

November 22, 2022

From Savara Inc.

Via Business Wire

Savara Reports Third Quarter 2022 Financial Results and Provides Business Update

November 10, 2022

From Savara Inc.

Via Business Wire

Savara to Participate in Three Upcoming Investor Conferences

November 09, 2022

From Savara Inc.

Via Business Wire

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

September 14, 2022

From Savara Inc.

Via Business Wire

Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022

September 06, 2022

From Savara Inc.

Via Business Wire

Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference

September 01, 2022

From Savara Inc.

Via Business Wire

Savara Announces Resignation of Chief Medical Officer

August 26, 2022

From Savara Inc.

Via Business Wire

Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

August 25, 2022

From Savara Inc.

Via Business Wire

Recap: Savara Q2 Earnings ↗

August 11, 2022

Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of...

Via Benzinga

Savara Reports Second Quarter 2022 Financial Results and Provides Business Update

August 11, 2022

From Savara Inc.

Via Business Wire

Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022

July 11, 2022

From Savara Inc.

Via Business Wire

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

June 16, 2022

From Savara Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 13, 2022

Gainers

Via Benzinga

Savara to Present at Jefferies Healthcare Conference

June 01, 2022

From Savara Inc.

Via Business Wire

Savara to Present at H.C. Wainwright Global Investment Conference

May 17, 2022

From Savara Inc.

Via Business Wire

Savara: Q1 Earnings Insights ↗

May 11, 2022

Savara (NASDAQ:SVRA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara beat estimated earnings by...

Via Benzinga

Savara Reports First Quarter 2022 Financial Results and Provides Business Update

May 11, 2022

From Savara Inc.

Via Business Wire

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

April 26, 2022

From Savara Inc.

Via Business Wire

The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial ↗

April 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank

April 22, 2022

From Savara Inc.

Via Business Wire

Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update

March 30, 2022

From Savara Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 18, 2022

Gainers

Via Benzinga

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

March 16, 2022

From Savara Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 27, 2022

Gainers Avidity Biosciences (NASDAQ:RNA) s...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.